Investors
View our range of topical creams, moisturisers and soap-alternatives uniquely formulated to relieve symptoms associated with various skin conditions including psoriasis, eczema, dandruff, scabies, fungal infections, and dry or irritated skin.
May 26, 2025
AFT Pharmaceuticals (NZX:AFT, ASX:AFP) today announces it has extended its US Maxigesic® licensing agreement with Hikma Pharmaceuticals….
May 1, 2024
We are delighted to announce our partnership with Brazil’s Halex Istar, and to be exclusively responsible for distributing its Maxigesic IV in Brazi…
April 24, 2024
AFT collaborate with Massey Ventures and Gilles McIndoe to begin the development of a topical treatment for keloid and hypertrophic scarring….